iBio
IBIO
#9670
Rank
NZ$0.10 B
Marketcap
NZ$4.70
Share price
14.89%
Change (1 day)
5.36%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2025 (TTM): NZ-$2.63

According to iBio's latest financial reports the company's current EPS (TTM) is NZ-$2.68. In 2024 the company made an earnings per share (EPS) of NZ-$11.30 an increase over its 2023 EPS that were of NZ-$184.68.

EPS history for iBio from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$2.63-76.73%
2024NZ-$11.30-93.88%
2023NZ-$184.68-8.14%
2022NZ-$201.0492.67%
2021NZ-$104.35-80.33%
2020NZ-$530.43-35.11%
2019NZ-$817.38-38.96%
2018NZ-$1,339-6.1%
2017NZ-$1,42636.67%
2016NZ-$1,04333.33%
2015NZ-$782.5950%
2014NZ-$521.73-53.85%
2013NZ-$1,130-7.14%
2012NZ-$1,217-64.1%
2011NZ-$3,39177.27%
2010NZ-$1,913144.44%
2009NZ-$782.5912.93%
2008NZ-$693.0112.2%
2007NZ-$617.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Genocea Biosciences
GNCA
NZ-$0.90-66.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.45-191.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$18.16-777.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ-$13.86 417.53%๐Ÿ‡บ๐Ÿ‡ธ USA